Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
35.34Price to Operating Cash Flow
VS
Market
Sector
Industry
History
$ 7.21Close
$ 3.43 - $ 14.41 52-Week Range
Ticker Information
Ticker
NAGECompany Name
NIAGEN BIOSCIENCE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQNIAGEN BIOSCIENCE INC - Price to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NAGE - P/OCF Historical data
| Date | Market Capitalization | Net Cash Flow - Operations | Price to Operating Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 749.68M | $ 21.21M | 35.34 |
| 3/31/2025 | $ 665.6M | $ 19.7M | 33.79 |
| 12/31/2024 | $ 435.4M | $ 12.11M | 35.96 |
| 9/30/2024 | $ 266.58M | $ 4.17M | 63.85 |
| 6/30/2024 | $ 199.7M | $ 1.08M | 185.6 |
| 3/31/2024 | $ 289.31M | $ 4.62M | 62.62 |
| 12/31/2023 | $ 131.04M | $ 7.12M | 18.41 |
| 9/30/2023 | $ 120.2M | $ 6.14M | 19.58 |
| 6/30/2023 | $ 123.8M | $ 2M | 61.78 |
| 3/31/2023 | $ 110.2M | $ -5.11M | 0 |
Key Performance Insights, Last 5 Years
- NIAGEN BIOSCIENCE INC's latest trailing twelve months (TTM) P/OCF stands at 0.
- Over the past 5 years, NIAGEN BIOSCIENCE INC's average P/OCF has been 57.44.
- The median P/OCF for NIAGEN BIOSCIENCE INC during this period was 35.96
- NIAGEN BIOSCIENCE INC reached its highest P/OCF over the past 5 years at 185.6.
- The lowest P/OCF recorded by NIAGEN BIOSCIENCE INC in the same timeframe 18.41
NIAGEN BIOSCIENCE INC's P/OCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/OCF Benchmarks
Similar metrics to P/OCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Price to Operating Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].Market Cap / CF - Operations
(=) P/OCF P/OCF for NIAGEN BIOSCIENCE INC is calculated as follows: Market Cap [ $ 295.35M ] / CF - Operations [ $ -11.23M ]
(=) P/OCF [ 0 ] NAGE - Price to Operating Cash Flow, Last 5 years
18.41
Minimum
Dec 31, 2023
185.6
Maximum
Jun 30, 2024
57.44
Average
35.96
Median
P/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.1 with a standard deviation of 8.81.
The following table provides additional summary stats:
P/OCF in the Market:
| filtered constituents | 2.56K |
|---|---|
| min | 0.08 |
| max | 42.03 |
| average | 13.1 |
| median | 10.77 |
| std | 8.81 |